A Phase I clinical trial of QA102 for dry age related macular degeneration
Latest Information Update: 10 Dec 2021
At a glance
- Drugs QA 102 (Primary)
- Indications Dry age-related macular degeneration
- Focus Adverse reactions
Most Recent Events
- 10 Dec 2021 New trial record